887 related articles for article (PubMed ID: 22981632)
1. Cancer stem cells.
Yu Z; Pestell TG; Lisanti MP; Pestell RG
Int J Biochem Cell Biol; 2012 Dec; 44(12):2144-51. PubMed ID: 22981632
[TBL] [Abstract][Full Text] [Related]
2. Cancer stem cells (CSCs) in cancer progression and therapy.
Najafi M; Farhood B; Mortezaee K
J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375
[TBL] [Abstract][Full Text] [Related]
3. Role of microRNAs in the regulation of breast cancer stem cells.
Liu S; Clouthier SG; Wicha MS
J Mammary Gland Biol Neoplasia; 2012 Mar; 17(1):15-21. PubMed ID: 22331423
[TBL] [Abstract][Full Text] [Related]
4. The biological kinship of hypoxia with CSC and EMT and their relationship with deregulated expression of miRNAs and tumor aggressiveness.
Bao B; Azmi AS; Ali S; Ahmad A; Li Y; Banerjee S; Kong D; Sarkar FH
Biochim Biophys Acta; 2012 Dec; 1826(2):272-96. PubMed ID: 22579961
[TBL] [Abstract][Full Text] [Related]
5. microRNAs in cancer stem cells: Biology, pathways, and therapeutic opportunities.
Asadzadeh Z; Mansoori B; Mohammadi A; Aghajani M; Haji-Asgarzadeh K; Safarzadeh E; Mokhtarzadeh A; Duijf PHG; Baradaran B
J Cell Physiol; 2019 Jul; 234(7):10002-10017. PubMed ID: 30537109
[TBL] [Abstract][Full Text] [Related]
6. Stem cell programs in cancer initiation, progression, and therapy resistance.
Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
[TBL] [Abstract][Full Text] [Related]
7. The Role of Cancer Stem Cells in Recurrent and Drug-Resistant Lung Cancer.
Suresh R; Ali S; Ahmad A; Philip PA; Sarkar FH
Adv Exp Med Biol; 2016; 890():57-74. PubMed ID: 26703799
[TBL] [Abstract][Full Text] [Related]
8. Targeting microRNAs in epithelial-to-mesenchymal transition-induced cancer stem cells: therapeutic approaches in cancer.
Garg M
Expert Opin Ther Targets; 2015 Feb; 19(2):285-97. PubMed ID: 25563894
[TBL] [Abstract][Full Text] [Related]
9. Advances in Therapeutic Targeting of Cancer Stem Cells within the Tumor Microenvironment: An Updated Review.
Dzobo K; Senthebane DA; Ganz C; Thomford NE; Wonkam A; Dandara C
Cells; 2020 Aug; 9(8):. PubMed ID: 32823711
[TBL] [Abstract][Full Text] [Related]
10. Non-coding RNAs Functioning in Colorectal Cancer Stem Cells.
Fanale D; Barraco N; Listì A; Bazan V; Russo A
Adv Exp Med Biol; 2016; 937():93-108. PubMed ID: 27573896
[TBL] [Abstract][Full Text] [Related]
11. Cancer Stem Cells: Acquisition, Characteristics, Therapeutic Implications, Targeting Strategies and Future Prospects.
Yadav AK; Desai NS
Stem Cell Rev Rep; 2019 Jun; 15(3):331-355. PubMed ID: 30993589
[TBL] [Abstract][Full Text] [Related]
12. Targeting cancer stem cell-specific markers and/or associated signaling pathways for overcoming cancer drug resistance.
Ranji P; Salmani Kesejini T; Saeedikhoo S; Alizadeh AM
Tumour Biol; 2016 Oct; 37(10):13059-13075. PubMed ID: 27561758
[TBL] [Abstract][Full Text] [Related]
13. MicroRNAs and cancer stem cells: the sword and the shield.
Sun X; Jiao X; Pestell TG; Fan C; Qin S; Mirabelli E; Ren H; Pestell RG
Oncogene; 2014 Oct; 33(42):4967-77. PubMed ID: 24240682
[TBL] [Abstract][Full Text] [Related]
14. The challenge of targeting cancer stem cells to halt metastasis.
Agliano A; Calvo A; Box C
Semin Cancer Biol; 2017 Jun; 44():25-42. PubMed ID: 28323021
[TBL] [Abstract][Full Text] [Related]
15. MicroRNAs involved in regulating epithelial-mesenchymal transition and cancer stem cells as molecular targets for cancer therapeutics.
Xia H; Hui KM
Cancer Gene Ther; 2012 Nov; 19(11):723-30. PubMed ID: 22975591
[TBL] [Abstract][Full Text] [Related]
16. Targeting cancer stem cells in solid tumors by vitamin D.
So JY; Suh N
J Steroid Biochem Mol Biol; 2015 Apr; 148():79-85. PubMed ID: 25460302
[TBL] [Abstract][Full Text] [Related]
17. The lipid rafts in cancer stem cell: a target to eradicate cancer.
Zhang S; Zhu N; Li HF; Gu J; Zhang CJ; Liao DF; Qin L
Stem Cell Res Ther; 2022 Aug; 13(1):432. PubMed ID: 36042526
[TBL] [Abstract][Full Text] [Related]
18. Signalling mechanism(s) of epithelial-mesenchymal transition and cancer stem cells in tumour therapeutic resistance.
Cai Z; Cao Y; Luo Y; Hu H; Ling H
Clin Chim Acta; 2018 Aug; 483():156-163. PubMed ID: 29709449
[TBL] [Abstract][Full Text] [Related]
19. Self-Renewal and Pluripotency in Osteosarcoma Stem Cells' Chemoresistance: Notch, Hedgehog, and Wnt/β-Catenin Interplay with Embryonic Markers.
Martins-Neves SR; Sampaio-Ribeiro G; Gomes CMF
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176108
[TBL] [Abstract][Full Text] [Related]
20. Resistance to Cell Death and Its Modulation in Cancer Stem Cells.
Safa AR
Crit Rev Oncog; 2016; 21(3-4):203-219. PubMed ID: 27915972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]